Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor
Open Access
- 1 December 2000
- journal article
- Published by Elsevier
- Vol. 275 (50), 39146-39151
- https://doi.org/10.1074/jbc.m006964200
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Development of Resistance to Insulin-like Growth Factor Binding Protein-3 in Transfected T47D Breast Cancer CellsBiochemical and Biophysical Research Communications, 1998
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Postsynthetic regulation of insulin-like growth factor-binding protein-3 by MCF-7 human breast cancer cells in cultureBreast Cancer Research and Treatment, 1996
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsPublished by Elsevier ,1996
- Insulin-like Growth Factor Binding Protein 3 (IGF-BP3) Inhibits Estrogen-Stimulated Breast Cancer Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell lineJournal of Cellular Physiology, 1994
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblastsBiochemical and Biophysical Research Communications, 1988